ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MBUU vs TMO // NET PROFIT MARGIN

Malibu Boats Inc. (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MBUU 3 — TMO 9
▲ NET PROFIT MARGIN LEADER: TMO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MBUU VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MBUU TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 17.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 3.50% 9.30% -5.80 TMO /roic <GO>
EV/EBITDA & P/E Valuation 10.0x 30.4x -20.40 MBUU /valuation <GO>
Free Cash Flow Yield 6.18% 2.40% +3.78 MBUU /fcf-yield <GO>
Operating Margin 2.70% 17.40% -14.70 TMO /operating-margins <GO>
Net Profit Margin ACTIVE 1.90% 15.10% -13.20 TMO /net-margins <GO>
Revenue Growth (YoY) -2.60% 3.90% -6.50 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.58 4.50 -0.92 TMO /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.5 62.9 -8.40 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 28.3x 36.3x -8.00 MBUU /forward-pe <GO>
Enterprise Scale & Market Cap $462.4M $262.22B -$261.75B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MBUU REV TMO REV MBUU GROSS % TMO GROSS % MBUU FCF TMO FCF
FY 2025 $807.6M $44.56B 17.8% — $28.6M $6.29B
FY 2024 $829.0M $42.88B 17.7% — -$20.4M $7.27B
FY 2023 $1.39B $42.86B — — $184.7M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MBUU // BETA —
TMO // BETA 0.94